Page 73 - UKRRptApr21

manufacturer of rolled steel in Ukraine. It specializes in production of long products, in particular, rebar and wire rod. ArcelorMittal owns the largest mining and metallurgical plant in Ukraine ArcelorMittal Kryvyi Rih and a number of small companies, in particular, PJSC ArcelorMittal Beryslav.
9.2.12 Other sector corporate news
Ukraine’s pharmaceutical market expanded by 13% in 2020 year-on-year to UAH41bn ($1.5bn), President of the Association Manufacturers of Medications of Ukraine (AMMU) Petro Bahriy said at a press conference at Interfax-Ukraine on March 30.
"In 2020, the market share of domestic manufacturers has grown. The entire market of Ukrainian medicines was UAH41bn. It grew by almost 13% compared to the previous year. Exports also grew by 7%," he said, as cited by Interfax Ukraine.
In 2020, the consumption of cold-relief medicines, medicines for digestive disorders and drugs that are used in the hospital segment decreased due to a decline in planned operations. At the same time, the COVID-19 group of drugs expanded, according to Bahriy.
At the same event the Director General of the SMD analytical company Iryna Horlova said that the entire volume of the pharmaceuticals market was worth $2.2bn in purchase prices excluding VAT as of the end of 2020.
According to the expert, 2020 brought more growth in monetary terms than the total cumulative growth over the previous five years.
Previously the market had been growing by 8% a year but this accelerated to 13% in 2020 due to the pandemic and thanks to the active participation of the state. At the same time, there is a significant decline in prices.
"The state had the largest share of purchases (28%). The state-funded market shows an increase of 92%, with almost $600mn. Among state-funded segments, the most successful and interesting is the work of the procurement agency Medical Procurement of Ukraine, which at the end of the year had 8% of the share of procurements and partially supplies of all medicines. The Ministry of Health held tenders for a total of $330mn, of which $170mn was the procurement of medicines," Horlova said adding that at the same time the retail segment stagnated.
In addition, in 2020 significantly fewer new products entered the market, while 93% of them entered the state-funded segment "because the companies responded to the request," the expert said.
She predicts that under an optimistic scenario in 2021 there will be growth, in particular in the budget-funded segment, but not so active, and retail will still be close to zero.
"In the next five years, most likely the Rx segment will occupy a fairly
73 UKRAINE Country Report April 2021 www.intellinews.com